starthome-logo 無料ゲーム
starthome-logo

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan


SYDNEY &SAN FRANCISCO, Mar 24, 2021 - (JCN Newswire) - TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost at any time, across one or all sites depending on recruitment needs.

With more than 80% of clinical trials failing to recruit patients on time, 30% of research sites not able to meet enrollment goals, and 10% of sites not able to enroll any patients, StudyBoost offers peace of mind for Clinical Directors and their CROs.

StudyBoost was designed so that sponsors avoid a trial rescue crisis, saving valuable time and money. If a study needs extra patients, StudyBoost can start delivering instantly and at a significantly reduced cost to normal recruitment. There are no project fees and there is a 50% fee reduction for enrolled patient success.

StudyBoost is ideal for sponsors and CROs wanting to avoid extended recruitment stalls while they find a recruitment firm and process engagement documentation which can take weeks. Which means a study has a recruitment booster plan ready to action at any time recruitment slows.

The package is only available from the start of a study. StudyBoost is available via the TrialWire self-serve portal, at https://www.trial-wire.com/studyboost/.

About TrialWire(TM) - www.trial-wire.com

The TrialWire(TM) Platform is the most secure service, using advanced algorithms to find the right people who are online that might be suitable for studies listed on the Platform. They are invited into the Platform and taken through the AI-Match screener to determine an exact match to a study-site based or remote/virtual.

No account sign-up is required to find and apply for a study. And unlike all other digital recruitment firms, TrialWire does NOT keep patient details - no databases so no potential privacy breaches. Sponsors are not paying for database building where patients are sent to other studies.

The Platform ingests study data from approved trial registries like ClinicalTrials.Gov. It uses advanced algorithms, SEO, search marketing, social media, respected news sites, and wellness blogs and more to find patient/trial matches. The algorithms find people based on detailed demographic and location profiles.

Key to TrialWire success is that it finds motivated people who are online actively trying to find out more about their conditions. These people can be connected to a site in under 2 minutes, and demonstrate the highest retention rates. Find out more about TrialWire at https://www.trial-wire.com.

Contact:
Sydney NSW AUS HQ, +61 2 8218 2145
Singapore APAC HQ, +65 3159 3427
San Francisco USA HQ, +1 415 951 3228
E: team@trial-wire.com, www.trial-wire.com


Copyright 2021 JCN Newswire. All rights reserved. www.jcnnewswire.com
    Loading...
    アクセスランキング
    1. AI動画生成 DomoAI ドモエイアイ Google最新AI Nano Banana Pro Gemini 3 Pro Image に対応し無制限生成が可能に 圧倒的な制作精度向上と効率化でワンストップAI生成

    2. GoogleがGemini 3発表 マルチモーダル強化で検索と開発基盤に同時展開

    3. 竹内順子「サスケが味方。その時期がどれだけ尊いか」激アツ忍者漫画コラボ!新作アニメ『NARUTO-ナルト-×NINKŪ-忍空-』全4話決定PV公開

    4. HitPaw Edimakor 4.6系列アップデート-Klingモーションコントロール&Vidu Q3 Proで AI 動画表現を進化

    5. まだ9月なのにインフル流行入り!? ワクチンは“打って終わり”じゃない、研究で分かったワクチンの効果(抗体応答)を左右する生活習慣とは

    6. 加工NG、ワンタップで即送信! Instagramが放つ新機能『Instants』。スクショ禁止&閲覧後消滅で、令和のSNSは「映え」から「ありのまま」へ完全シフト

    7. AI動画生成 DomoAI ドモエイアイ トーキングアバター機能強化で音声 感情 会話表現がより人間らしくリアルに マルチボイス 動画素材入力 スクリプト自動分割などアップデート

    8. YouTube、AI動画の開示機能を刷新 システム検知で自動ラベル付与

    9. インフルエンザは冬だけじゃない!異例の早期流行「オフピークインフルエンザ」に備える日常の対策とは

    10. HitPaw Edimakor、AIによる【テキストから動画生成】機能を新搭載――構成もAIで自動化

    game_banner
    Starthome

    StartHomeカテゴリー

    Copyright 2026
    ©KINGSOFT JAPAN INC. ALL RIGHTS RESERVED.